Video Intervention for Smoking Cessation
Trial Summary
What is the purpose of this trial?
The purpose of the current study is to pilot the efficacy, feasibility, and acceptability of an evidence-based smoking cessation intervention adapted for cancer patients and delivered via video. Investigators aim to assess if this intervention is considered acceptable by participants, feasible to implement, and effective at increasing knowledge about smoking cessation before conducting a fully powered clinical trial.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on smoking cessation for cancer patients.
What data supports the effectiveness of the VIDeOS Smoking Cessation Program treatment?
Research shows that behavioral treatments, like those used in the VIDeOS program, can help people quit smoking, with some programs achieving long-term success rates of up to 50%. Additionally, social support and relapse prevention training, which are often part of video-based interventions, have been shown to improve quitting success.12345
What makes the VIDeOS Smoking Cessation Program unique compared to other smoking cessation treatments?
Research Team
Eligibility Criteria
This trial is for adults over 18 who have any type of cancer, are currently smoking cigarettes, and receiving care at the Medical University of South Carolina. Participants must be able to read and understand English.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete surveys prior to randomization to assess baseline knowledge and smoking behaviors
Intervention
Participants receive either video interventions or NCI pamphlets for smoking cessation
Follow-up
Participants complete surveys to assess acceptability, feasibility, and changes in smoking behaviors and knowledge
Treatment Details
Interventions
- VIDeOS (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical University of South Carolina
Lead Sponsor
Dr. Erik Summers
Medical University of South Carolina
Chief Medical Officer
MD from University of Alabama at Birmingham
Dr. Patrick J. Cawley
Medical University of South Carolina
Chief Executive Officer
MD, MBA
Alliance NCORP Research Base Cancer Control Program
Collaborator
National Cancer Institute (NCI)
Collaborator
Dr. Douglas R. Lowy
National Cancer Institute (NCI)
Chief Executive Officer since 2023
MD from New York University School of Medicine
Dr. Monica Bertagnolli
National Cancer Institute (NCI)
Chief Medical Officer since 2022
MD from Harvard Medical School